CRISPR Therapeutics AG
- Biological Products, Except Diagnostic Substances
- Zug, Switzerland
Compensation history
Top executives at CRISPR Therapeutics AG received an average of $4M per person in annual compensation from 2015 to 2021.
By year
Executives
We found nine executives who work or worked at CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Rodger Novak
CRISPR Therapeutics AG
President
Marc Becker
CRISPR Therapeutics AG
Chief Financial Officer
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019
About CRISPR Therapeutics AG
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Biological Products, Except Diagnostic Substances
- Baarerstrasse 14, Zug, Switzerland CH-6300
- 6173154600
- December 31